Clinical Trials Browser

Phase 1/2 × AP 1903 reagent × 1 year × Clear all

Cytokine Release Syndrome, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma